127 related articles for article (PubMed ID: 31587598)
1. Imiquimod-oleic acid prodrug-loaded cream reduced drug crystallinity and induced indistinguishable cytotoxicity and apoptosis in mice melanoma tumour.
Sharma A; Sharma D; Baldi A; Jyoti K; Chandra R; Madan J
J Microencapsul; 2019 Dec; 36(8):759-774. PubMed ID: 31587598
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effect of Imiquimod enhanced ALA-PDT on cutaneous squamous cell carcinoma.
Bhatta AK; Wang P; Keyal U; Zhao Z; Ji J; Zhu L; Wang X; Zhang G
Photodiagnosis Photodyn Ther; 2018 Sep; 23():273-280. PubMed ID: 30030167
[TBL] [Abstract][Full Text] [Related]
3. Self-assembled mPEG-hexPLA polymeric nanocarriers for the targeted cutaneous delivery of imiquimod.
Lapteva M; Mignot M; Mondon K; Möller M; Gurny R; Kalia YN
Eur J Pharm Biopharm; 2019 Sep; 142():553-562. PubMed ID: 30641138
[TBL] [Abstract][Full Text] [Related]
4. Microemulsions based on TPGS and isostearic acid for imiquimod formulation and skin delivery.
Pescina S; Garrastazu G; Del Favero E; Rondelli V; Cantù L; Padula C; Santi P; Nicoli S
Eur J Pharm Sci; 2018 Dec; 125():223-231. PubMed ID: 30316975
[TBL] [Abstract][Full Text] [Related]
5. Imiquimod inhibits melanoma development by promoting pDC cytotoxic functions and impeding tumor vascularization.
Aspord C; Tramcourt L; Leloup C; Molens JP; Leccia MT; Charles J; Plumas J
J Invest Dermatol; 2014 Oct; 134(10):2551-2561. PubMed ID: 24751730
[TBL] [Abstract][Full Text] [Related]
6. Topical treatment of melanoma skin metastases with imiquimod: a review.
Sisti A; Sisti G; Oranges CM
Dermatol Online J; 2015 Feb; 21(2):. PubMed ID: 25756475
[TBL] [Abstract][Full Text] [Related]
7. Imiquimod Exerts Antitumor Effects by Inducing Immunogenic Cell Death and Is Enhanced by the Glycolytic Inhibitor 2-Deoxyglucose.
Huang SW; Wang ST; Chang SH; Chuang KC; Wang HY; Kao JK; Liang SM; Wu CY; Kao SH; Chen YJ; Shieh JJ
J Invest Dermatol; 2020 Sep; 140(9):1771-1783.e6. PubMed ID: 32035924
[TBL] [Abstract][Full Text] [Related]
8. Imiquimod-induced ROS production disrupts the balance of mitochondrial dynamics and increases mitophagy in skin cancer cells.
Chuang KC; Chang CR; Chang SH; Huang SW; Chuang SM; Li ZY; Wang ST; Kao JK; Chen YJ; Shieh JJ
J Dermatol Sci; 2020 Jun; 98(3):152-162. PubMed ID: 32376151
[TBL] [Abstract][Full Text] [Related]
9. Co-Delivery of Imiquimod and Curcumin by Nanoemugel for Improved Topical Delivery and Reduced Psoriasis-Like Skin Lesions.
Algahtani MS; Ahmad MZ; Nourein IH; Ahmad J
Biomolecules; 2020 Jun; 10(7):. PubMed ID: 32605030
[TBL] [Abstract][Full Text] [Related]
10. The TLR7 agonist imiquimod induces anti-cancer effects via autophagic cell death and enhances anti-tumoral and systemic immunity during radiotherapy for melanoma.
Cho JH; Lee HJ; Ko HJ; Yoon BI; Choe J; Kim KC; Hahn TW; Han JA; Choi SS; Jung YM; Lee KH; Lee YS; Jung YJ
Oncotarget; 2017 Apr; 8(15):24932-24948. PubMed ID: 28212561
[TBL] [Abstract][Full Text] [Related]
11. Pro-apoptotic activity of nano-escheriosome based oleic acid conjugate against 7,12-dimethylbenz(a)anthracene (DMBA) induced cutaneous carcinogenesis.
Khan AA
Biomed Pharmacother; 2017 Jun; 90():295-302. PubMed ID: 28364601
[TBL] [Abstract][Full Text] [Related]
12. Novel imiquimod nanovesicles for topical vaccination.
Caimi AT; Altube MJ; de Farias MA; Portugal RV; Perez AP; Romero EL; Morilla MJ
Colloids Surf B Biointerfaces; 2019 Feb; 174():536-543. PubMed ID: 30500742
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of imiquimod skin penetration.
Telò I; Pescina S; Padula C; Santi P; Nicoli S
Int J Pharm; 2016 Sep; 511(1):516-523. PubMed ID: 27452419
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of IL-17-committed T cells in a murine psoriasis model by a vitamin D analogue.
Kusuba N; Kitoh A; Dainichi T; Honda T; Otsuka A; Egawa G; Nakajima S; Miyachi Y; Kabashima K
J Allergy Clin Immunol; 2018 Mar; 141(3):972-981.e10. PubMed ID: 28870465
[TBL] [Abstract][Full Text] [Related]
15. Insight into imiquimod skin permeation and increased delivery using microneedle pre-treatment.
Al-Mayahy MH; Sabri AH; Rutland CS; Holmes A; McKenna J; Marlow M; Scurr DJ
Eur J Pharm Biopharm; 2019 Jun; 139():33-43. PubMed ID: 30771455
[TBL] [Abstract][Full Text] [Related]
16. Imiquimod activates p53-dependent apoptosis in a human basal cell carcinoma cell line.
Huang SW; Chang SH; Mu SW; Jiang HY; Wang ST; Kao JK; Huang JL; Wu CY; Chen YJ; Shieh JJ
J Dermatol Sci; 2016 Mar; 81(3):182-91. PubMed ID: 26775629
[TBL] [Abstract][Full Text] [Related]
17. Design, Development, and Characterization of Imiquimod-Loaded Chitosan Films for Topical Delivery.
Layek B; Rahman Nirzhor SS; Rathi S; Kandimalla KK; Wiedmann TS; Prabha S
AAPS PharmSciTech; 2019 Jan; 20(2):58. PubMed ID: 30623265
[TBL] [Abstract][Full Text] [Related]
18. Phospholipid-Based Microemulsions for Cutaneous Imiquimod Delivery.
Panoutsopoulou E; Zbytovská J; Vávrová K; Paraskevopoulos G
Pharmaceuticals (Basel); 2022 Apr; 15(5):. PubMed ID: 35631342
[TBL] [Abstract][Full Text] [Related]
19. Imiquimod cream efficacy in the treatment of periocular nodular basal cell carcinoma: a non-randomized trial.
de Macedo EM; Carneiro RC; de Lima PP; Silva BG; Matayoshi S
BMC Ophthalmol; 2015 Apr; 15():35. PubMed ID: 25885553
[TBL] [Abstract][Full Text] [Related]
20. Imiquimod-induced AMPK activation causes translation attenuation and apoptosis but not autophagy.
Wang ST; Huang SW; Kao JK; Liang SM; Chen YJ; Chen YY; Wu CY; Shieh JJ
J Dermatol Sci; 2015 May; 78(2):108-16. PubMed ID: 25766763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]